Politics
JPMorgan Raises Eaton Price Target to $440 Amid Analyst Upgrades
Eaton Corporation (NYSE:ETN) has received an increase in its price target from JPMorgan Chase & Co., which raised its projection from $429.00 to $440.00. This adjustment was detailed in a research report issued on Thursday. JPMorgan currently holds an overweight rating on the industrial products company, reflecting positive sentiment about its future performance.
Several other analysts have also recently updated their assessments of Eaton. On August 20, 2023, Rothschild Redb upgraded the stock to a “hold” rating. Meanwhile, the Royal Bank of Canada lifted its price target from $425.00 to $432.00, maintaining an “outperform” rating. Conversely, Wall Street Zen changed its stance, downgrading Eaton from a “buy” to a “hold” rating on September 13, 2023. Additionally, Raymond James Financial raised its target price from $380.00 to $415.00, while Daiwa Capital Markets initiated coverage with an “outperform” rating and a price target of $390.00.
Analysts are generally optimistic about Eaton’s prospects. Currently, one analyst has assigned a Strong Buy rating, eighteen have a Buy rating, and six have given a Hold rating. As per data from MarketBeat.com, Eaton has a consensus rating of “Moderate Buy” with an average price target of $403.23.
Earnings Report and Dividend Announcement
Eaton reported its latest quarterly earnings on November 4, 2023, revealing earnings per share (EPS) of $3.07, slightly surpassing analysts’ expectations of $3.06. The company’s revenue for the quarter totaled $6.99 billion, falling short of the anticipated $7.09 billion. Eaton’s net margin stood at 15.11%, and its return on equity was 23.91%. For the fourth quarter of 2025, Eaton has projected EPS guidance between $3.230 and $3.430, while the fiscal year 2025 guidance is set at $11.970 to $12.170.
In addition to its earnings report, Eaton announced a quarterly dividend of $1.04 per share, scheduled for payment on November 21, 2023. Shareholders on record by November 6, 2023 will be eligible for this dividend, which translates to an annualized dividend of $4.16 and a yield of 1.1%. The company’s current dividend payout ratio is 41.60%.
Insider Activity and Institutional Investments
Recent insider trading activity has also been noteworthy. On October 31, 2023, Gerald Johnson, a director at Eaton, purchased 100 shares at an average price of $384.33 per share, amounting to a total investment of $38,433.00. Following this transaction, Johnson’s ownership in Eaton increased by 100%, bringing his total shares held to 200, valued at approximately $76,866. Currently, insiders own around 0.30% of Eaton’s stock.
Institutional investors have been actively adjusting their stakes in Eaton as well. In the third quarter, Burling Wealth Partners LLC acquired a new stake valued at approximately $2,594,000, while Redmont Wealth Advisors LLC entered a new position worth $40,000. Additionally, Syon Capital LLC increased its holdings by 5.5%, now owning 7,345 shares valued at $2,749,000. Crestwood Advisors Group LLC and Rothschild Investment LLC have also made significant adjustments to their positions. Overall, institutional investors and hedge funds hold approximately 82.97% of Eaton’s stock.
Eaton Corporation continues to demonstrate strong performance and investor interest, supported by positive analyst ratings and strategic insider activity. The company’s robust financial results and quarterly dividend further bolster its position in the industrial sector.
-
Science3 weeks agoInventor Achieves Breakthrough with 2 Billion FPS Laser Video
-
Health4 weeks agoCommunity Unites for 7th Annual Into the Light Walk for Mental Health
-
Top Stories4 weeks agoCharlie Sheen’s New Romance: ‘Glowing’ with Younger Partner
-
Entertainment4 weeks agoDua Lipa Aces GCSE Spanish, Sparks Super Bowl Buzz with Fans
-
Business4 weeks agoTyler Technologies Set to Reveal Q3 Earnings on October 22
-
Entertainment4 weeks agoMother Fights to Reunite with Children After Kidnapping in New Drama
-
World4 weeks agoR&B Icon D’Angelo Dies at 51, Leaving Lasting Legacy
-
Health4 weeks agoCurium Group, PeptiDream, and PDRadiopharma Launch Key Cancer Trial
-
Science4 weeks agoNorth Carolina’s Biotech Boom: Billions Invested in Manufacturing
-
Health4 weeks agoNorth Carolina’s Biotech Boom: Billions in New Investments
-
Entertainment4 weeks agoRed Sox’s Bregman to Become Free Agent; Tigers Commit to Skubal
-
Top Stories3 weeks agoFormer Mozilla CMO Launches AI-Driven Cannabis Cocktail Brand Fast
